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We used our voluntary rat model of reaching and grasping to study the eﬀect of performing a high-repetition and high-force
(HRHF) task for 12 weeks on wrist joints. We also studied the eﬀectiveness of ibuprofen, administered in the last 8 weeks,
in attenuating HRHF-induced changes in these joints. With HRHF task performance, ED1+ and COX2+ cells were present
in subchondral radius, carpal bones and synovium; IL-1alpha and TNF-alpha increased in distal radius/ulna/carpal bones;
chondrocytes stained with Terminal deoxynucleotidyl Transferase- (TDT-) mediated dUTP-biotin nick end-labeling (TUNEL)
increased in wrist articular cartilages; superficial structural changes (e.g., pannus) and reduced proteoglycan staining were observed
in wrist articular cartilages. These changes were not present in normal controls or ibuprofen treated rats, although IL-1alpha
was increased in reach limbs of trained controls. HRHF-induced increases in serum C1,2C (a biomarker of collagen I and II
degradation), and the ratio of collagen degradation to synthesis (C1,2C/CPII; the latter a biomarker of collage type II synthesis)
were also attenuated by ibuprofen. Thus, ibuprofen treatment was eﬀective in attenuating HRHF-induced inflammation and early
articular cartilage degeneration.
1. Introduction
Work-related upper limb disorders in the United States are
estimated to cost over $61.2 billion annually. In 2006, the
number of occupational injuries involving days away from
work due to hand and wrist injuries was 47,020 and 56,250,
respectively, while their incidence rates were 10.6% of 29.5%
total in the upper extremity [1, 2]. In the United Kingdom,
115,000 new cases of work-related upper limb disorders, also
known as repetitive strain injury (RSI), were reported in
2006-2007 compared with 86,000 new cases in 2005-2006,
and the number of people reporting problems with RSIs rose
from 374,000 to 426,000 [3, 4]. Similar increases are reported
by the French National Health Insurance Fund-Occupational
Risks, who further break down major work-related muscu-
loskeletal disorders (MSDs) by body region [5]. Their data
indicate that the number of new occupational cases resulting
in settlement related to peri-articular disorders of the wrist
increased 42% in 2009, compared to 17% in the elbow, 6.9%
in the back and 2.2% in the knee.
Degeneration of joints, including radiocarpal and intra-
carpal joints, is known to be the result of inter-related trau-
matic (e.g., a quantitative increase or qualitative aberration
in joint loading), inflammatory and metabolic processes
[6–8]. Epidemiological studies provide evidence for links
between occupational physical activities that involve highly
repetitive arm motions and other risk factors for MSDs
(e.g., awkward posture, force, duration) and hand and
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wrist disorders, and between occupational physical activities
and increased incidence of hand osteoathritis (OA) [9–11].
For example, high incidence of radiographic of hand OA
has been identified in middle-aged female dentists and
teachers [10, 11]. In the elderly population, the prevalence
of radiographic hand OA can reach 80% [12]. Several studies
report that increasing radiographic severity of hand OA is
associated with reduced hand function and pain [10, 13, 14].
Therefore, the impact of hand OA is considerable [13, 14].
Several animal models have been used to explore the
development of joint degeneration, with the goal of studying
the progression of early arthritis and eﬀects of therapeutic
interventions. These models lead to a degenerative progres-
sion similar to humans, such as from instability-induced
joint degeneration, spontaneous degeneration in various
strains of mice, use of knockout mice, mice overexpressing
certain bone proteins (e.g., overexpression of Runx2 [15–
21]). However, several of the initiating factors in these animal
models are not representative of the inducing factors in the
general population.
We have developed a unique, voluntary rat model of
repetitive reaching and grasping that permits the exami-
nation of responses of upper limb tissues to cumulative
muscular loads [22–32]. This model requires adult rats to
voluntarily and repetitively reach for, grasp, and isometrically
pull a handle with one forelimb, while the contralateral limb
provides postural support, and while both reach rate and
force are controlled by food reward criteria. We have shown
that a low-demand task (low-repetition and negligible-force;
LRNF) induced a low-level and transient inflammatory
cytokine tissue response [25, 29], while a moderate-demand
task (high-repetition and negligible-force; HRNF) induced a
moderate inflammatory cytokine response in musculoskele-
tal tissues, and early pathological woven bone remodeling at
distal periosteal-bone sites by 6 weeks of task performance
that resolved by 12 weeks [28–30]. The LRNF task regimen
consisted of 3.3 reaches/min at <5% estimated maximum
pulling force (<9.85 g), while the HRNF task regimen
consisted of the same force requirements but 8 reaches/min.
Thus, we observed a loading-level dependent inflammatory
cytokine response with these two task regimens. In terms of
pathological bone remodeling, we observed periosteal hyper-
plasia, particularly at sites of tendon and muscle attachments
to the radius and ulna, and increased cellularity (increased
osteoclasts and their progenitor cells, and osteoblasts) in
distal cortical bones of the radius and ulna, as well as
disruption of laminar bone organization in the HRNF bones.
The cellular changes peaked between 4 and 6 weeks but
returned to normal by 12 weeks of performance of the HRNF
task. Also, by 12 weeks, HRNF task-induced disorganized
collagen fibers of the periosteum had begun to regain their
closely packed parallel alignment, and lamellar organization
was more similar to control bone [30]. These latter findings
are indicative of bone adaptation to the cumulative loading
of this moderate demand task.
In contrast, bone adaptation was not evident with
continued performance of higher-demand tasks (e.g., mod-
erate repetition with high-force (MRHF) or high-repetition
with high-force (HRHF)), tasks requiring 60% maximum
isometric pulling force (an average of 118 g), for 2 hours/day
and 3 days/week [23, 32]. Instead of resolution of the
inflammatory response, we observed continued (chronic)
inflammatory responses in nerve and musculoskeletal tissues
and increased pathological bone remodeling that was again
dependent on the level of the task, with the greatest changes
observed with the HRHF task [23, 26, 31, 32]. With 12 weeks
of performance of an HRHF task, we observed significantly
decreased height of the distal radial and ulnar epiphyseal
plates, decreased cortical bone thickness, reduction in a bone
matrix repair molecule (periostin like factor), and increased
Trap5b (a serum marker of osteoclast activity and bone
resorption [31, 32]). Thus, we have observed the induction of
pathological bone changes with higher-demand tasks in our
animal model, a task that incorporates both a quantitative
increase in bone loading and cumulative loading. However,
the influence of the high-demand tasks on joint tissues has
not been assessed in our model, nor has the inflammatory
response in bones of HRHF rats past 6 weeks of task
performance. Continued exploration of the inflammatory
response using this rat model in which repetition and force
requirements can be varied with operant behavioral training,
and in which inflammation (or at least aspects of it) is
attenuated with anti-inflammatory drugs, is needed to fully
understand the links between biomechanical factors and
inflammation.
One purpose of this study was to evaluate the potential
of a voluntary HRHF rat model to induce inflammation
and articular cartilage degeneration in radiocarpal and
intracarpal joints. We hypothesized that performance of an
HRHF forearm/hand intensive task would induce increased
inflammatory cytokines and the onset of degenerative
changes in wrist joint structures. A second purpose was to
determine the eﬀectiveness of oral ibuprofen, a nonselective
cyclooxygenase inhibitor, on these outcomes, since oral
ibuprofen is a commonly used nonselective nonsteroidal
anti-inflammatory drug (NSAID) for the treatment of OA
[33–37]. We hypothesized that a steady dose of ibuprofen
would attenuate the increase in inflammatory cytokines that
we have previously observed in the distal radius and ulna
and carpal bones in our model, albeit when induced by
lower-demand tasks [25, 29]. We further hypothesized that
use of ibuprofen would contribute to an attenuation of any
observed radiocarpal and intracarpal cartilage degenerative
changes despite continued loading of the joints from con-
tinued task performance during the ibuprofen treatment,
although the ability of ibuprofen to attenuate articular
cartilage degenerative changes is controversial and still under
investigation [35–37].
2. Materials and Methods
2.1. Animals. Animal care and use were monitored by the
University Animal Care and Use Committee to assure com-
pliance with the provisions of Federal and National Institute
of Health regulations. Eighty-seven adult female Sprague-
Dawley rats (3.5 months of age at onset of experiments)
were obtained fromACE (Boyertown, PA). They were housed
in separate cages in a 12-hour light/dark cycle. Rat weights
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were measured weekly throughout the study. All trained
and task animals were food restricted for no longer than
1 week to no less than 80% of full body weight during
the first week of the initial training period when they first
began learning the task. However, during the remaining 5
weeks of training, they were maintained at ±5% of age-
matched normal controls with rat chow daily to supplement
the food pellets used for food reward (45mg purified formula
food pellets; Bioserve, Frenchtown, NJ). All rats were given
free access to water throughout the experiment. Trained
only control rats matched experimental animals by age
and weight, and were sacrificed at matched time points.
Normal controls with free access to food were matched to
experimental animals by age and weight (within ±5% after
the first week), and were sacrificed at matched time points.
Eighty-seven animals were randomly assigned to one of
six groups. There were two experimental groups: rats trained
to perform an HRHF task without ibuprofen for 12 weeks
(HRHF, n = 18), and HRHF rats that received ibuprofen
treatment (HRHF + IBU, n = 15). There were four control
groups: trained controls (TR, n = 14), TR that received
ibuprofen treatment (TR + IBU, n = 11), untrained normal
controls (NC, n = 19), and NC that received ibuprofen
treatment (NC + IBU, n = 10).
2.2. Behavioral Apparatus, Training Procedures, and Task
Performance. The behavioral apparatuses used were as
described and depicted previously [26, 38]. Briefly, force
apparatuses custom designed by Ann Barr and Custom
Medical Research Equipment (Glendora, NJ, USA) were used
that were integrated into a computerized operant behavioral
training system (Med Associates, Georgia, VT, USA with
Force Lever software, version 1.03.02, Med Associates). A
portal was located in the chamber walls at shoulder height
(3.5 cm), requiring shoulder elevation and elbow extension
for the animal to reach through the portal to a custom-
designed force handle attached to a force transducer located
1.5 cm away from the portal entrance, outside the chamber
wall. An auditory indicator cued the animals to reach. HRHF
rats had to grasp the force handle and exert an isometric pull
toward the chamber wall for at least 50milliseconds with a
graded force eﬀort of 60 ± 5% average maximum pulling
force (MPF; 108.35 g to 128.05 g range of pulling force), as
determined on the last day of training. If these force and
time criteria were met within a 5-second cueing period, an
indicator light turned on and a 45mg purified formula food
pellet (banana flavored; Bioserve, NJ, USA) was dispensed
into a trough located at floor height of the chamber. Animals
were allowed to use their preferred limb to reach, which
was recorded. The contralateral limb was used as a postural
support limb throughout the reach and pull task.
Sprague-Dawley rats were 3.5 month old at the onset
of the experiment. Fifty-eight rats were trained to perform
a repetitive handle-pulling task with food reward using
standard operant conditioning procedures during a 6-week
training period. During this training period, rats learned the
HRHF task in the operant test chamber until they could
reach into the tube dispenser with no specified reach rate at
60 ± 5% maximum pulling force for 10min/day. Once the
animals were able to perform the task consistently (usually
after 6 weeks), rats were randomly divided into trained only
control (TR) and HRHF groups. Then the HRHF animals
(n = 33) began the task regimen at a rate of 12 reaches/min
at 60 ± 5% MPF, for 2 h/day, 3 days/week for 12 weeks. The
daily task was divided into four, 0.5-hour training sessions
separated by 1.5 hour. The TR rats (n = 25) did not perform
beyond this initial training period.
2.3. Ibuprofen Treatment. At the end of the 4th week of
task performance, subcohorts of the above animals were
administered ibuprofen (Children’s Motrin Grape Flavored,
Johnson & Johnson) in drinking water daily (45mg/kg body
weight): NC+IBU (n = 10), TR + IBU (n = 11) and
HRHF + IBU (n = 15). HRHF+IBU animals continued to
perform the HRHF task regimen with ibuprofen treatment
for the remainder of the 12-week task period (i.e., an 8-
week course of ibuprofen treatment). The dose used was
lower than the maximum limit for gastrointestinal toxicity
in rats, yet has been shown to be eﬀective in reducing
chronic inflammation [39]. The amount of medicated water
consumed/day was tracked for each animal by measuring the
diﬀerence between the initial and final volume of suspended
solution daily. Serum levels of ibuprofen were confirmed
using National Medical Services (Willow Grove, PA). Based
on these assessments, the average weekly ibuprofen dose was
similar in all groups (48.8 ± 6.3mg/kg body weight), with
no significant diﬀerences in ibuprofen dose administered or
serum levels of ibuprofen between the treated groups.
2.4. Wrist Measurement. Wrist girth was measured in mil-
limeters for all animals using an electronic caliper (Mitutoyo
Vernier Pointed Jay Caliper, model 536-121) immediately
after anesthesia (see the following) and before euthanasia.
2.5. Tissue Collection for Cytokine Analysis. Following
euthanasia by sodium pentobarbital (Nembutol, 120mg/kg
body weight), wrist joints (distal radius and ulna metaphysis
and epiphysis and articular cartilage, and the first row of
carpal bones) were collected from subcohorts of animals: NC
(n = 7) and NC + IBU (n = 6), TR (n = 6), TR + IBU
(n = 5), HRHF (n = 6), and HRHF + IBU (n = 6). Elbow
joints (proximal radius and ulna, and distal humerus) were
also collected. Tissues were flash-frozen, homogenized, and
assessed for interleukin (IL)-1α, IL-1β, tumor necrosis factor
(TNF)α, IL-6 and IL-10, using commercially available ELISA
kits (Bio-Source, Invitrogen Life Sciences, CA) as described
previously [29]. The sensitivity of the assays was <3 pg/mL
for IL-1α and IL-1β, <0.7 pg/mL for TNF-α, <7 pg/mL for IL-
6, and <5 pg/mL for IL-10. Each sample was run in duplicate.
ELISA assay data (pg cytokine protein) were normalized to
μg total protein, which was determined using a bicinchoninic
acid (BCA) protein assay kit.
2.6. Histopathological Grading System for Degenerative Chan-
ges. Following euthanasia by sodium pentobarbital (Nem-
butol, 120mg/kg body weight), subcohorts of animals were
perfused transcardially with 4% paraformaldehyde in 0.1M
PO4 buﬀer (pH 7.4): NC (n = 8), NC + IBU (n = 5),
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TR (n = 5), TR + IBU (n = 6), HRHF (n = 9), and HRHF +
IBU (n = 6). Bilateral radius and ulna, with attached carpal
bones and ligaments were collected, decalcified, paraﬃn
embedded and sectioned into 5 μm longitudinal sections
as described previously [30]. Morphological changes in
radial articular cartilage were assessed using these paraﬃn
embedded sections after staining with Safranin O and
fast green. A modified Mankin scoring system was used,
which was derived from three subscores: (1) structure, (2)
cellular abnormalities, and (3) matrix staining, as described
previously [17, 40–42]. Within each subscore there was a
range of possible values. Within the structure subscore, there
were 7 possible scores: 0 = normal structure, 1 = irregular
surface (including fissures into the radial layer), 2 = pannus, 3
= superficial cartilage layers absent, 4 = slight disorganization
(cellular rows absent, some small superficial clusters), 5 =
fissures into calcified cartilage layer, and 6 disorganization
≥25% (chaotic structure, clusters, osteoclast activity). The
cellular abnormalities subscore had 4 grades: 0 = normal,
1 = hypercellularity (including small superficial clusters),
2 = clusters, and 3 = hypocellularity. The matrix staining
subscore had 5 grades: 0 = normal or slight reduction in
staining, 1 = staining reduced in radial layer, 2 = reduced in
interterritorial layer, 3 = only present in pericellular matrix,
and 4 = staining absent. The scoring system was supple-
mented with half points. Intratester reliability in scoring
was assessed: Zone 1 ICC(3,1) = 0.91, Zone 2 ICC(3,1)
= 0.85, Zone 3 ICC(3,1) = 0.66, and Zone 4 ICC(3,1) =
0.76. Additional sections stained with hematoxylin and eosin
(H&E) were also used to evaluate articular cartilage structure
and cellular subscores. These changes were assessed in a
blinded manner by one rater; a second blinded investigator
also evaluated 30% of the joints to verify the appropriate
score. Each radiocarpal joint was assessed in four zones,
progressing from the radial margin (zone 1) to the ulnar
margin (zone 4) of the distal radius articular cartilage (see
Figure 3(a)). If a joint had a questionable appearance (e.g.,
tears or folds produced during slide preparation), adjacent
sections were evaluated. Changes in SafraninO and fast green
in the epiphyseal plate were also examined qualitatively.
Also, the reach limb’s distal forelimb bones of nine
additional rats (NC, n = 3; TC, n = 3; HRHF, n = 3;
and HRHF + IBU, n = 3) did not undergo decalcification,
but were dehydrated with ethylene glycol monoethyl (Fisher,
Fair Lawn, NJ, USA), cleared in methyl salicylate (J.T. Baker,
Phillipsburg, NJ), and embedded in methyl methacrylate
with 15% dibutyl phthalate (Fisher Scientific, Pittsburgh,
PA). Bones were cut into 5 μm longitudinal sections using
a diamond saw. These sections were stained with Safranin
O and fast green for qualitative assessment purposes and for
confirmation of results from decalcified, paraﬃn embedded
sections.
2.7. Immunohistochemistry and Histochemistry. Immunohis-
tochemistry was also performed on the paraﬃn-embedded
bone sectioned to qualitatively assess the presence of
cyclooxygenase 2 (COX 2), ED1 (a marker of acti-
vated macrophages, osteoclasts, and their progenitors), and
inflammatory cytokine (IL-1α, TNF-α, and IL-10) stained
cells in radiocarpal articular cartilage, bone, synovium, and
ligaments. Bones were prepared and immunostained for ED1
and inflammatory cytokines using antibodies (Millipore,
Billerica, MA) and methods described previously [23, 30,
32]. Sections for single-labeling or fluorescence double-
labeling were immunostained with anti-COX2 (sc-1745;
Santa Cruz Biotechnology Inc, Santa Cruz, CA) at 1 : 300
dilution in phosphate buﬀer using similar methods as
previously described [29, 38].
Terminal deoxynucleotidyl Transferase- (TDT-) medi-
ated dUTP-biotin nick end-labeling (TUNEL) was per-
formed in adjacent paraﬃn-embedded sections using a TACS
TdT kit according to manufacturer’s directions (catalog
number TA4625, R&D Systems, Inc). Briefly, after decalcifi-
cation, sections were washed in PBS, treated with Proteinase
K solution (in kit) for 15 minutes, and washed with dH2O,
immersed in quenching solution for 5 minutes, washed in
PBS, immersed in 1X TdT solution for 5 minutes, incubated
with Labeling Reaction Mix for 1 hour at 37◦C, immersed
in Stop Buﬀer for 5 minutes at room temperature, washed
with dH2O and then PBS before treating with 0.3% H2O2
in PBS for 30 minutes before washing again. Sections were
then reacted with streptavidin-HRP for 10 min at 37◦C,
washed with PBS, reacted with DAB solution for 5 minutes,
washed with dH2O, dehydrated through a series of increasing
alcohol solutions and then xylene before coverslipping with
DPX mounting media. Sections were not counterstained.
Staining controls included a positive control slide (stomach)
in which TUNEL staining should be and was present, an
unlabeled control slide that showed no brown staining, a
TACS-Nuclease-treated control slide (which showed only
pale brown staining in most cells), and sections of distal
radius/ulna/carpal bones from normal controls rats.
2.8. Collection of Serum and Measurement of C1, 2C, and
CPII. Following euthanasia (which occurred at 18 hrs after
completion of the final task session), blood was collected
fromNC (n = 11), NC+ IBU = 6, TR (n = 9), TR + IBU (n =
6), HRHF (n = 13) and HRHF + IBU rats (n = 6), by cardiac
puncture using a 23-gauge needle into plain plastic 15mL
tubes, placed on ice for 30min, and centrifuged at 1,000 g for
20min at 4◦C. Serum was then collected, flash-frozen, and
stored at −80◦C until analyzed. ELISA was used to measure
serum concentrations of C1, 2C, also known as COL2 3/4
C short (IBEX Technologies, Inc., Montreal, Quebec). This
assay measures types I and II collagen degradation using a
specific polyclonal antibody to their primary cleavage sites;
this antibody recognizes α-chain fragments produced by
collagenase cleavage (by matrix metalloproteinase- (MMP)
1,MMP-8,MMP-13) of type II collagen. ELISA was also used
to measure serum concentrations of CPII, a collagen type
II synthesis biomarker that is also known as procollagen II
C-propeptide (IBEX Technologies, Inc). This assay measures
intact C-propeptide using a specific polyclonal antibody to
the type II collagen carboxy propeptide cleaved from type
II procollagen following the release of newly synthesized
procollagen into the matrix. Data for C1, 2C are presented as
ng/ml serum. Data for CPII are presented as part of the ratio
of collagen degradation to synthesis markers (C1,2C/CPII).
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2.9. Statistical Analyses. All data were analyzed with descrip-
tive and interferential statistics using Prism Graph Pad.
Statistical significance was based on a P ≤ .05. All measures
of variance are reported as standard error of the mean.
Wrist girth was assayed using one-way ANOVA. ELISA data
were analyzed using a two-way ANOVA with the factors
group and limb (reach and support limbs). Each cytokine
was analyzed separately within a 6 × 2 ANOVA. Significant
findings were assessed with the Bonferroni method of post
hoc testing, with adjusted P values, in which data from all
groups and limbs, per cytokine, were compared to each other
(the adjusted P value for significance was≤.002). For the his-
tological scoring data, total scores for each zone were initially
analyzed using paired-sample t-tests with Bonferroni correc-
tions to assess diﬀerences between the four zones. We found
that all zones of the articular cartilage were significantly
diﬀerent from control levels except for zones 1 and 4. Because
these two zones were on the margins of the articular cartilage
and may represent a transitional region of articular cartilage,
only zones 2 and 3 were analyzed further. Thus, a 6 (group)
× 2 (limb) × 2 (zones 2 and 3) ANOVA with zone treated as
a within subjects variable was performed to assess diﬀerences
in histopathological articular cartilage scores between groups
and limbs. Limbs were found to not significantly diﬀer
from each other; therefore, their data were combined to
assess diﬀerences using a two-way ANOVA with the factors
group and zone (zones 2 and 3). Significant findings for
averaged total scores and individual subscores were assessed
with appropriate follow-up one-way ANOVAs. Significant
findings were then assessed with the Bonferroni method of
post hoc testing, with adjusted p values, in which data from
all groups were compared to each other. A one-way ANOVA
was performed to assess diﬀerences between groups in C1,
2C serum concentrations and the C1, 2C/CPII ratio, each
followed by the Bonferroni corrected post hoc test method.
3. Results
3.1. Wrist Girth. Wrist girth was assayed to determine if
there was swelling at this joint as a consequence of task
performance. No changes from NC levels were found (P =
.53). For example, the wrist girth in HRHF was 6.30 ±
0.09mm (mean± SEM) compared to 6.18±0.16mm in NC.
3.2. Increase of Cox 2 and ED1+ Cells in Wrist Joint Articular
Cartilage, Synovium and Ligaments. We initially examined
NC and HRHF distal ulna, radiocarpal joint and carpal
bones for increased immunoexpression of COX 2. As shown
in Figure 1, compared to NC (Figures 1(a) and 1(b)),
we found increased COX2 immunopositive (+) chondro-
cytes in the distal radius articular cartilage and adjacent
synovium (Figures 1(c) and 1(d)), distal ulna articular
cartilage and carpal bone articular cartilages (Figure 1(e))
in HRHF rats. We also observed increased COX2+ cells
in the radiocarpal (Figures 1(e)s and 1(f)) and intracarpal
ligaments in HRHF rats compared to NC (NC not shown).
Many of the COX2+ cells in the synovium were ED1+
macrophages (Figures 1(g)–1(i)). Therefore, NC, TR, TR
+ IBU, HRHF, and HRHF + IBU wrist joints were also
evaluated for the presence of ED1+ cells (a marker of
macrophages, osteoclasts and their progenitors). In HRHF
reach limbs, ED1+ mononucleated cells were identified in
the subchondral bone adjacent to articular cartilage in the
distal radius (Figure 1(k)). Many ED1+ mononucleated cells
were also observed in subchondral regions of carpal bones
(Figure 1(l), arrows). NC lacked ED1+ cells in subchondral
regions of radial and carpal bones (Figure 1(j)), as did TR
and TR + IBU rats (data not shown). A small number of
ED1+ cells were observed in the same areas in the HRHF
+ IBU rats, however there were no significant diﬀerences
between the number of number of ED1+ cells in HRHF
+ IBU and NC rats (P > .05 both before and after the
Bonferroni adjustment of the P value; data not shown). This
increase in COX2+ and ED1+ cells in HRHF wrist joint
structures, increases that were attenuated by the ibuprofen
treatment, further justified the use of ibuprofen, an anti-
inflammatory drug, as an intervention in this study.
3.3. Increased Inflammatory Cytokines in Distal Radius, Ulna
and Carpal Bones. Since we have previously identified an
increase of several proinflammatory cytokines (e.g., TNF-
α and IL-1α) in musculoskeletal tissues in response to the
HRHF task when performed for 6 weeks, and the eﬀective-
ness of an anti-TNF-α drug in attenuating their increases
[31], we extended that investigation in this study to examine
their production at 12 weeks, as well as the eﬀectiveness of
ibuprofen in attenuating this potential increase since ibupro-
fen is a commonly used NSAID. Biochemical analysis of joint
inflammation was assessed in homogenized wrist joints using
ELISA. IL-1α levels were highest in the distal forelimb bones
of HRHF reach limbs, compared to NC, NC + IBU, TR, TR +
IBU and HRHF + IBU (P < .01 each; Figure 2(a)), and in the
HRHF reach limb compared to the support limb (P < .05;
Figure 2(a)). It was also higher in the TR reach limbs than
in NC (P < .01) and NC + IBU (P < .05). IL-1α levels were
not increased in the support limbs of TR rats compared to
NC due to the use of Bonferroni corrections and adjusted P
values; however, we should note here that the 2-way ANOVA
for this cytokine showed no significant diﬀerences between
limbs (P = .57) including in the TR rats.
TNF-α levels were highest in both the HRHF reach and
support limbs compared to all other groups (P < .01 each;
Figure 2(b)). IL-10 levels were highest in TR distal forelimb
bones, bilaterally, compared to NC, NC + IBU, and HRHF +
IBU (P < .01 each, Figure 2(c)), and in the TR reach limb
compared to TR + IBU and HRHF reach limbs (P < .05
each; Figure 2(c)). IL-10 was also elevated in TR + IBU reach
limb compared to NC (P < .05) and in the TR-IBU limbs,
bilaterally, compared to HRHF + IBU (P < .05 each), and in
HRHF compared to NC + IBU limbs (P < .01 for reach limb,
P < .05 for support limb) (Figure 2(c)). IL-6 levels showed
significant diﬀerences by group (P = .005), with significant
post hoc findings of decreased IL-6 in TR, bilaterally, and in
TR + IBU and HRHF + IBU reach limbs, compared to NC
+ IBU (P < .05 each; Figure 2(e)). IL-1β levels also showed
significant diﬀerences by group (P = .03), but no significant
post hoc findings (Figure 2(d)). Immunohistochemistry was
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Figure 1: Immunohistological staining cyclooxygenase 2 (COX 2) and ED1 in HRHF distal radiocarpal articular cartilage, synovium and
ligaments of longitudinally sections of paraﬃn embedded bones. ED1 detects a 90 kDa lysosomal membrane glycoprotein in osteoclasts,
phagocytic macrophages and their progenitors. (a)–(f) COX 2 staining was visualized using DAB intensified with cobalt (black signal); light
hematoxylin and eosin ((h) and (e)) staining was used as a counterstain. (a) No COX 2 immunostaining was observed in distal radial articular
cartilage and synovium of a normal control (NC). (b) Higher-power image of same section as shown in (a). (c) COX2+ cells are present in
the articular cartilage and synovium of a 12-week high-repetition high-force (HRHF) rat’s distal radius. (d) Higher-power image of same
section as shown in (c). (e) COX2+ cells are present in the distal radial articular cartilage and radiocarpal ligament of a 12 week HRHF rat.
(f) Higher-power image of same section as shown in (e). (g)–(i) Several COX2+ cells are present in the radiocarpal synovium of an HRHF 12
rat (red cells). (g) Same section double labeled for ED1 (green cells, (h)). (i) Merged photo. Arrow indicates a group of COX2+/ED1+ double
labeled cells. (j) ED1+ cells (brown DAB signal) were absent in distal radius articular cartilage of an NC rat. Section is lightly counterstained
with hematoxylin. (k) Mononucleated ED1+ cells (arrows, presumably osteoclast progenitor cells) were observed in the subchondral bone
of the distal radius of an HRHF rat. (l) ED1+ cells were also present in HRHF carpal bones. Scale bars = 50 μm. b: bone, c: articular cartilage,
lig: ligament, s: synovium.
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Figure 2: Cytokine concentrations in reach and support wrist joint (distal most radius, distal ulna, first row of carpal bones, and associated
joint regions), tested using ELISA. Levels of (a) Interleukin (IL)-1α, (b) tumor necrosis factor (TNF)-α, (c) IL-10, (d) IL-1β, and (e) IL-6
are shown for NC (normal control), NC + IBU (normal controls receiving ibuprofen for 8 weeks), TR (trained controls), TR + IBU (trained
controls receiving ibuprofen treatment in final 8 weeks), HRHF (rats performing high-repetition high-force task for 12 weeks), and HRHF
+ IBU (HRHF rats receiving ibuprofen treatment in final 8 weeks). Abbreviations: 1 = P < .05 compared to NC, 2 = P < .05 compared to
NC + IBU, 3 = P < .05 compared to TR; 4 = P < .05 compared to TR + IBU; 5 = P < .05 compared to HRHF + IBU; a = support limb is
significantly diﬀerent from reach limb, P < .05.
used to determine that IL-1α and TNF-α immunoreaction
product was present in synovial cells and chondrocytes of the
articular cartilage (data not shown). We also observed using
double-labeling immunohistochemistry that most of the
small ED1+ mononucleated cells were also immunoreactive
for IL-1α and TNF-α, matching results of several previous
studies in our lab showing expression of inflammatory
cytokines by ED1 immunoreactive cells in musculoskeletal
and nerve tissues [23, 28, 38].
To determine if the increases in cytokines were
widespread throughout the forelimb, we also examined
the same 5 cytokines in reach limb elbow joints. None were
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Figure 3: Distal radii and carpal bones stained with safranin O and fast green. (a)–(g) are longitudinal sections of paraﬃn embedded radius,
ulna and carpal bones. (a)–(c) Low-power micrographs showing distal radius, scaphoid bones and articular cartilage in (a) NC (normal
control), (b) TR (trained control), and (c) HRHF rat (performed the high-repetition high-force task for 12 weeks). (a) also indicates the
4 zones of the articular cartilage assessed in the radius. (d)–(g) Higher-power images showing the distal radii articular cartilage of (d)
untreated TR, (e) TR + IBU (trained controls receiving ibuprofen treatment in final 8 weeks), (f) HRHF, and (g) HRHF + IBU rats. (f)
demonstrates an HRHF animal with structural changes (surface pannus, arrows), cellular changes (hypocellularity in areas indicated with
∗), and dramatically reduced proteoglycan staining in the articular cartilage (red-pink safranin O staining). The inset in (f) is a higher-power
micrograph from another HRHF rat showing chondrocytes that appear to be proliferating. The inset in (g) shows a higher-powermicrograph
from area indicated with arrow that also contains proliferating chondrocytes. (h)-(i) Loss of safranin O staining in HRHF articular cartilage
was verified in plastic embedded bones that were also cut longitudinally. Radii and scaphoid articular cartilages of (h) HRHF and (i) HRHF
+ IBU are shown. Scale bars = 50 μm. B: bone, S: scaphoid bone.
significantly increased above NC levels, indicating that the
elbow joint was not aﬀected by performance of this hand
and wrist intensive repetitive task. For example, IL-1α levels
were 0.15 ± 0.01 (mean ± SEM) pg/μg of total protein in
HRHF compared to 0.22 ± 0.04 in NC; TNF-α was 0.35 ±
0.05 in HRHF compared to 0.37 ± 0.04 in NC.
In summary, increased IL-1α and TNF-α levels were
present in the wrist joints (but not elbow joints) of HRHF
rats compared to the other groups. These increases were
attenuated by the ibuprofen treatment. IL-10 was highest in
the TR rat wrist joints, but ibuprofen treatment in TR + IBU
rats did not return IL-10 to baseline levels, suggesting that
ibuprofen may be working through diﬀerent mechanisms
than IL-10 signaling cascades.
3.4. Histopathological Changes in the Distal Radial Articular
Cartilage and Intracarpal Joints. We next investigated the
distal radius articular cartilage for morphological changes
occurring as a result of HRHF task performance and the
eﬀectiveness of secondary ibuprofen treatment in atten-
uating these changes. Figure 3(c) shows a low-power mi-
crograph of HRHF radiocarpal joint with reduced safranin
O staining in the radioscaphoid interterritorial articular
cartilage, compared to NC (Figure 3(a)) and TR rats
(Figure 3(b)). Higher-power micrographs show similar
results (Figures 3(d)–3(i)). Reduced intraterritorial and
pericellular proteoglycan staining (reduced safranin O
staining) and structural changes (surface pannus, arrows)
were observed in radial articular cartilages in untreated
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HRHF rats (Figures 3(f) and 3(h)), when compared to
untreated TR (Figure 3(d)), TR + IBU (Figure 3(e)) or
HRHF + IBU rats (Figures 3(g) and 3(i)). Cellular changes
were also observed in the untreated HRHF rats, such as
hypocellularity, which is indicative of cell loss (see areas indi-
cated with∗ in Figures 3(f) and 3(h)). Hypocellularity could
also be observed in HRHF + IBU rats, although to a much
lesser extent than in untreated HRHF rats (see Figure 3(i)).
Finally, clustered chondrocytes were observed in untreated
HRHF radial articular cartilage (see inset in Figures 3(f)
and 3(h)). Chondrocyte clustering was also observed in
HRHF + IBU rats, although, again to a much lesser extent
than in untreated HRHF (see inset in Figures 3(g) and 3(i)).
Clustering was not observed in TR, TR IBU or NC.
These changes were quantified using a modified Mankin
scoring method, with results shown in Figure 4. As shown in
Figure 4(a), each radiocarpal joint was assessed in four zones:
zone 1 was the radial edge of articular cartilage, zone 2 was
a radial area of articular cartilage ulnar to zone 1, zone 3 was
an area of cartilage ulnar to zone 2, and zone 4 was the ulnar
edge of the articular cartilage. All zones of articular cartilage
were significantly diﬀerent from control levels except zones
1 and 4. Because these two zones were on the margins of the
articular cartilage and may represent a transitional region
of articular cartilage, only zones 2 and 3 were analyzed
further.
The ANOVA for the overall histopathological scores of
the distal radius articular cartilage demonstrated signifi-
cant main eﬀects for zone (zones 2 and 3) and group
(Figure 4(a)), with the highest scores present in HRHF rats.
The histopathological score in HRHF rats for zone 2 was
slightly higher than that for zone 3 (Figure 4(a)). The aver-
aged total Mankin score for both zones combined was also
highest in HRHF rats compared to all groups (Figure 4(b)).
We also assessed the subcomponents of the Mankin scoring
system separately (Figures 4(c)–4(h)). Structural subscores
in zone 2 ranged from 25% to 43% greater in the HRHF
than in the other groups (mean score shown in Figure 4(c)).
Thirty-three percent of the HRHF had more pronounced
changes in the superficial layer (e.g., pannus) than in the
other groups. None of the animals had structural changes
beyond the superficial layers. Cellular scores were from 46
to 58% greater in the HRHF than those in the other groups,
in both zones 2 and 3 (mean scores shown in Figures 4(e)
and 4(f)). All but one of the HRHF rats had chondrocyte
clustering; 22% had regions of hypocellularity indicative of
cell loss within the articular cartilage. Thirty-three percent
of the HRHF + IBU had chondrocyte clustering (defined
as hypercellularity with superficial clusters, and graded as
1), but none had hypocellular regions. Safranin O staining
subscores were 79 to 257% greater (i.e., reduced proteoglycan
staining) in the HRHF than in the other groups (mean scores
shown in Figures 4(g) and 4(h)). All HRHF rats had reduced
staining in the interterritorial matrix, 44% had staining only
in the pericellular matrix, and one had a total absence of
staining. Among the animals that did not perform the HRHF
task, which includes NC, NC + IBU, TR and TR + IBU,
only 38% had reduced staining in the interterritorial matrix.
Ibuprofen treatment attenuated the reduction in staining in
HRHF rats (Figures 4(g) and 4(h); P < .01).
Distal radii and carpal bones probed for presence of cells
with Terminal deoxynucleotidyl Transferase (TDT) medi-
ated dUTP-biotin nick end-labeling (TUNEL). No TUNEL-
stained cells were observed in the articular cartilages of radial
bones in NC (Figures 5(a) and 5(g)) or TR rats (Figure 5(b)).
Only a few TUNEL-labeled cells were seen in HRHF + IBU
treated wrist articular cartilage (Figure 5(c)). In contrast,
the radial bones of 5 of the 9-untreated HRHF rats showed
scattered TUNEL-stained cells in the articular cartilages in
zones 2 and 3 (zone 2 is shown in Figure 5(f); zone 3 is shown
in Figures 5(d) (right side of photo) and 5(e)) and several
TUNEL-stained cells at the edges of zone 4 (ulnar margin of
radius; Figure 5(h)) and zone 1 (lateral or radial margin; left
side of Figure 5(d)). This latter finding is interesting as these
are sites of ligament attachments, such as the radiocarpal
ligament shown in Figure 5(h). No TUNEL-stained cells
were visible at the site of ligament attachment to the radius
in the other groups (NC shown in Figure 5(g)). Most of
the TUNEL-labeled cells observed in the HRHF radial
articular cartilage were apoptotic in appearance (exhibited
dark nuclear staining and cell condensation typically; Figures
5(i) and 5(j)). However, a few cells were also observed
that were both swollen and had TUNEL staining in the
cytoplasm as well as the nucleus, suggestive of necrosis (see
inset of Figure 6(d)). In summary, modest morphological
degenerative changes including reduced protoglycan staining
and increased TUNEL-stained cells were present in radial
articular cartilages of HRHF rats, changes attenuated by
ibuprofen treatment.
Similar morphological changes were observed in the
carpal bone articular cartilage located in intra-carpal
joints. HRHF rats (Figure 6(b)) had reduced Safranin O
and clustering (arrows) when visually compared to NC
(picture not shown), TR (Figure 6(a)) and HRHF + IBU
rats (Figure 6(c)). Again, ibuprofen treatment attenuated
staining decreases observed in HRHF rats (compare Figures
6(b) to 6(c)). Epiphyseal plate changes were also observed in
HRHF rats compared to the other groups. While Figure 3(c)
shows patchy Safranin O staining in the epiphyseal plate of
an HRHF rat, other HRHF rats had even greater losses, with
a complete absence of Safranin O staining in the epiphyseal
plates of a few (Figure 6(d)), compared to HRHF + IBU
(Figure 6(e)), NC (Figure 3(a)) and TR (Figure 3(b)) rats.
3.5. Increased Serum Biomarkers of Collagen Degradation. To
validate the histological findings, C1, 2C, a serum biomarker
of type I and II collagen degradation fragments was assessed.
The HRHF had higher C1, 2C serum levels than NC, NC
+ IBU, TR + IBU and HRHF + IBU (P = .01 ANOVA;
Figure 7(a)), indicating greater collagen degradation in
HRHF rats and its attenuation by IBU treatment. Serum
was also evaluated for the CPII epitope, a serum biomarker
reflective of type II collagen synthesis. Serum levels of CPII
were significantly higher in HRHF rats compared to NC,
TR and TR + IBU (P = .006 ANOVA; Figure 7(b)). The
ratio of collagen degradation to synthesis (C1, 2C/CPII) was
also higher in HRHF rats compared to NC, NC + IBU, and
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Figure 4: Histopathological Mankin scores shown for distal radius articular cartilage of the reach limb in NC (normal control), NC + IBU
(normal controls receiving ibuprofen for 8 weeks), TR (trained controls), TR + IBU (trained controls receiving ibuprofen treatment in final 8
weeks), HRHF (rats performing high-repetition high-force task for 12 weeks), and HRHF + IBU (HRHF rats receiving ibuprofen treatment
in final 8 weeks). (a) Total scores for zones 2 and 3 are presented separately by group. (b) Mean of total scores for both zones 2 and 3. (c)
Mankin score for structural changes in zone 2. (d) Mankin score for structural changes in zone 3. (e) Mankin score for cellular changes
in zone 2. (f) Mankin score for cellular changes in zone 3. (g) Mankin score for staining changes in zone 2. (h) Mankin score for staining
changes in zone 3. Abbreviations: 1 and 2 = P < .05 and P < .01, respectively, compared to NC. 3 and 4 = P < .05 and P < .01, respectively,
compared to TR; 5 and 6 = P < .05 and P < .01, respectively, compared to TR + IBU; 7 and 8 = P < .05 and P < .01, respectively, compared
to HRHF + IBU. 2∗ = P < .001 when comparing zones 2 and 3 (zone 2 is higher). Statistical results compared to NC + IBU are not presented
as they were comparable to NC results.
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Figure 5: Distal radii and carpal bones stained with TUNEL (longitudinal sections of paraﬃn embedded radius and carpal bones). (a)–(f)
Micrographs showing distal radius articular cartilage (indicated as c, for cartilage) in (a) NC (normal control), (b) TR (trained control), and
(c) HRHF + IBU (performed the high-repetition high-force task for 12 weeks and received ibuprofen treatment daily in last 8 weeks), (d)-(e)
HRHF rat (12 weeks HRHF rat with no treatment). (d) is a lower-power photo showing medial edge of radius and increased TUNEL stained
cells at that edge as well as stained cells in adjacent articular cartilage. Inset shows higher-power image of indicated cell. (e) is a higher-power
photo of same section shown in (d). (f) shows the radial articular cartilage from a diﬀerent rat than shown in (d) and (e). (g) Image showing
the lateral edge of the radius of an NC rat at the site of the attachment of the radiocarpal ligament. (h) Image showing the lateral edge of
the radius of an HRHF rat at the site of the attachment of the radiocarpal ligament. (i) Higher-power photo of same cell as indicated in (f)
with an arrow. (j) Higher-power photo of same cell as indicated in (h) with an arrow. Scale bars = 50 μm. b: bone, c: articular cartilage, lig:
radiocarpal ligament, s: synovial ligament.
HRHF + IBU (P = .02 ANOVA; Figure 7(c)), indicating
again greater collagen degradation in HRHF rats and its
attenuation by IBU treatment. Significant post hoc findings
are indicated in Figure 7.
4. Discussion
Numerous animal models have been employed to examine
the eﬀects of mechanical loading on joint structures;
however, only a few studies have examined the eﬀect of
loading on upper extremity joint structures (e.g., [43, 44]).
Our model is nonsurgical and involves performance of a
voluntary repetitive task to induce mechanical loading of
forearm tissues. We selected the HRHF task as we have
previously observed soft tissue and bone inflammation as
well as degenerative changes, including bone pathological
reorganization, using this task level [26, 32, 38, 45]. The
purpose of this study was to assess the potential of this
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Figure 6: Carpal bone articular cartilages (intracarpal joints) and epiphyseal plates from longitudinal sections of paraﬃn embedded bone
that were stained with safranin O and fast green. (a)–(c) Carpal bone articular cartilages in (a) TR (trained controls), (b) HRHF (rats
performing high-repetition high-force task for 12 weeks), and (c) HRHF + IBU (HRHF rats receiving ibuprofen treatment in final 8 weeks).
Reduced safranin O staining and a paucity of cells in lower cartilage layers are present in an HRHF rat, compared qualitatively to TR and
HRHF + IBU. Chondrocytes that appear to be proliferating are present in the HRHF carpal articular cartilage (arrows). (d)-(e) Distal
epiphyseal plate of the radius showing (d) an HRHF rat with a near absence of safranin O staining (arrowheads) and an irregularly shaped
epiphyseal plate, as compared to (e) HRHF+ IBU rat with an intensely stained and thicker epiphyseal plate. Scale bars = 50 μm. epi: epiphyseal
plate.
high-demand hand-and-wrist intensive loading task in
inducing inflammation and articular cartilage degeneration
in radiocarpal and intracarpal joints, and to determine the
eﬀect of ibuprofen on these outcomes. After 12 weeks of
performing the HRHF task, animals demonstrated evidence
of joint inflammation (elevated inflammatory cytokine levels
in distal radius, ulna and carpal bones, as well as increased
ED1+ and COX2+ cells), the onset of joint degeneration (ele-
vated modified Mankin histopathological scores in the distal
radius articular cartilage, and increased TUNEL-labeled cells
in the distal radius articular cartilage and attachment site of
ligaments to the distal radius), increased C1, 2C (a biomarker
of collagen degradation), and an increase in the ratio of
collagen degradation to synthesis (C1, 2C/CPII). Eight weeks
of ibuprofen administration reduced all of these changes,
despite continued task performance and thus continued
muscular loading during the 8 weeks treatment period of
the HRHF + IBU group. This last finding indicates that the
joint degenerative changes observed were a consequence of
the inflammatory response induced by this high-repetition
high-force task that was 12 weeks in duration.
We observed that 12 weeks of the HRHF task induced
joint inflammation at the wrist, but not the elbow. This
suggests that the cumulative loading during the 12 weeks
task period of this high-repetition high-force handle pulling
task aﬀects distal structuresmore than proximal. This finding
matches previous reports from our lab in which a high-
repetition negligible-force (HRNF) task induced significantly
higher numbers of ED1+ macrophages and osteoclasts in
distal hand and wrist musculoskeletal tissues than in elbow
and shoulder tissues [28, 30].
Concerning possible diﬀerential limb loading, IL-1
appeared more elevated in the distal bones/wrist joints of
reach limbs than support limbs of TR and HRHF rats. Prior
studies from our lab show that HRHF reach limbs had greater
increases of several analytes than support limbs, including
Substance P (a nociceptor neurotransmitter released after
tissue injury/inflammation) and connective tissue growth
factor (CTGF, a matricellular protein) in flexor digitorum
tendons, and CTGF in the median nerve [26, 38]. However,
these studies also show that IL-1β in tendons, grip strength
declines, and nerve conduction velocity declines were similar,
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Figure 7: Serum concentrations of collagen degradation and synthesis markers, and the ratio of collagen degradation to synthesis in NC
(normal control), NC + IBU (normal controls receiving ibuprofen for 8 weeks), TR (trained controls), TR + IBU (trained controls receiving
ibuprofen treatment in final 8 weeks), HRHF (rats performing high-repetition high-force task for 12 weeks), and HRHF + IBU (HRHF rats
receiving ibuprofen treatment in final 8 weeks). (a) C1, 2C, a marker of collagen Type I and II cleavage (degradation). (b) CPII, a marker of
procollagen II C-propeptide synthesis. (c) Ratio of C1, C2 (degradation) to CPII (synthesis). 1 = P < .05 and 2 = P < .01 compared to NC; 3
= P < .01 compared to NC + IBU; 4 = P < .05 compared to TR; 5 = P < .05 compared to TR + IBU; 6 = P < .01 compared to HRHF + IBU.
bilaterally, in HRHF-trained and task rats [26, 38]. Since
this HRHF task was a bilateral task, in which one limb
reached and pulled the lever isometrically, and the other limb
pushed against the chamber wall (see [38] for a depiction of
this task), one has to be careful not to over interpret limb
diﬀerences.
Our observed increases in cytokines in the distal bone
and joint was not unexpected since degenerative joint
osteoarthritis is associated with low-level inflammation
within a joint [6, 46, 47], and therefore, reduction of
inflammation should attenuate degenerative processes. For
example, increases of IL-1α, TNF-α and IL-10 have been
reported in various tissues undergoing joint osteoarthritic
degenerative changes (see [47] for a review), including artic-
ular cartilage [48–51], synovial membranes [46, 48] and sub-
chondral bone [48]. In terms of the roles of these cytokines in
joint degeneration, TNF-α, for example, has been postulated
to have a significant role in degradative cartilage changes
associated with OA, since OA cartilage produces more TNF-
α and TNF alpha convertase enzyme mRNA than normal
cartilage, and human articular chondrocytes from OA car-
tilage express higher amounts of p55 TNF-α receptors which
could make OA cartilage particularly susceptible to TNF-α
degradative stimuli [47]. In this current study, it was interest-
ing that IL-10, an anti-inflammatory mediator, was highest
in trained controls in this study, although it is unclear if this is
a beneficial response to the training experience or a reaction
to a simultaneous increase of IL-1α. A recent study assessed
biochemical markers in synovium and synovial fluid between
early- and late-stage knee osteoarthritis [52]. They found
that 3 inflammatory mediators (IL-1β, IL-6, and TNF-α) in
the synovium and synovial fluid were not significantly diﬀer-
ent between subsets. However, they also found that synovial
fluid IL-15 concentrations were significantly greater in the
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early-stage than in the late-stage subset. The precise role of
IL-15 in osteoarthritis is unclear, but it may be associated
with proinflammatory and catabolic processes [52].
With regard to the ED1+ cells, our past studies show
that activated macrophages and osteoclasts (both ED1+)
are immunoreactive for several inflammatory cytokines,
including IL-1α and TNF-α [28, 30, 38]. Since macrophages
are known to secrete pro-inflammatory cytokines after
injury, which, through autocrine regulation, induce further
secretion of cytokines from this cell type, the increase of
each with task performance and then decrease of each with
ibuprofen treatment were [33] not unexpected in our study.
In concordance with human osteoarthritis, the HRHF
task increased the number of cells in articular cartilage
[53] and synovium [54–56] that were expressing COX-2,
an enzyme associated with inflammation regulation. COX-2
expression is particularly elevated in synovium from early-
stage joint degeneration [55, 56] and when chondrocytes
experience high shear stresses [57]. We hypothesize that
the HRHF task induced early joint degeneration after 12
weeks due to possible increased shear stresses on the articular
cartilage, although this is hard to test in this in vivo model.
We can only point out that the attenuation of COX-2 staining
by ibuprofen, a nonselective COX inhibitor, combined with
the attenuation of inflammatory cytokine levels, indicates
that ibuprofen was at a therapeutic concentration.
We also observed that 12 weeks of performance of this
HRHF task increased histopathological scores of radiocarpal
joint degeneration. Our previous studies, using either this
HRHF task or a more moderate HRNF task, have shown
task-induced signs of injury and degeneration in forearm
nerve, muscles, tendons and cortical bone [26–28, 30, 32,
38, 45]. In this study, the increased histopathological scores
in untreated HRHF radiocarpal cartilage were primarily
attributed to changes in staining and cellular subscores
(e.g., decreased proteoglycan staining, surface irregularities,
and increased clustering). Only three of 9 HRHF wrist
joints had signs of definite structural changes (e.g., pannus),
but 5 HRHF wrist joints showed increased TUNEL-labeled
cells, indicative of the onset of task-induced chondrocyte
apoptosis. The primary change was a loss of proteoglycan
staining in radiocarpal cartilage as detected with Safranin
O. Based on previous animal and human research, and
based on the presence of TUNEL staining, if the HRHF
task continued beyond 12 weeks, the degenerative changes
would presumably worsen and propagate throughout the
joint [17, 19, 41, 58, 59]. Since the histopathological scores
were higher in the radial zone compared to the ulnar zone
of radial articular cartilage, the radial region of this articular
cartilage appears to be the initial site of joint degeneration
in the reach limbs. This site is likely aﬀected first because
the forceful grasping in a pronated position increases the
loading on the radial aspect of the articular cartilage. In the
more radial zone, HRHF + IBU was not statistically diﬀerent
from HRHF. However, in a more ulnar zone (zone 3) these
two groups were statistically diﬀerent. We can only speculate
that one reason for the zonal diﬀerences is that the radial
zone began losing proteoglycans prior to week 4 (prior to
when ibuprofen was administered) so the diﬀerence between
the two groups was reduced. In contrast, zone 3 may have
begun to lose proteoglycans closer to the start of ibuprofen
treatment (or after), and therefore seems to demonstrate
the diﬀerences between groups. Other nonsurgical joint
degeneration models (e.g., undefined causes, spontaneous or
knockout models) also report proteoglycan depletion and
superficial cell clustering at 8 to 12 weeks and structural
changes at 6 months of age [18, 58, 59].
In addition to degenerative changes in the distal radius
articular cartilage, HRHF carpal bones also showed signs
of degenerative changes compared to the other groups.
Unfortunately, the Mankin histopathological scoring sys-
tem could not be used to score the articular cartilage
morphology of rat carpal bones due to distinctive surface
morphology diﬀerences in carpal bones compared to radial
articular cartilage. However, degenerative carpal changes
with HRHF were further supported by the presence of ED1+
mononucleated cells in subchondral carpal bone regions
(see Figure 2(c)). Osteoclast progenitor cells are indicators
of subchondral bone remodeling, a common feature of early
joint degeneration [19].
The histopathological data indicative of cartilage degen-
erative changes were confirmed by increased serum C1, 2C
(a marker of collagen types 1 and 2 degradation fragments
produced by collagenase cleavage of type II collagen),
increased CPII (a biomarker of procollagen II C-propeptide
and thus collagen type II synthesis), and the increase in
the ratio of C1, 2C to CPII (i.e., increased ratio of collagen
degradation to synthesis). We have previously reported an
early increase in serum osteocalcin (a biomarker of bone
formation) by 6 weeks of performance of the HRHF task,
which then decreased; and an increase in serum Trap5b (a
biomarker of osteoclast activity and bone resorption) by 12
weeks [32]. The increase in serum osteocalcin was matched
temporally by morphological and biochemical indicators
of early bone adaptation changes, while the increase in
serum Trap5b was matched temporally by morphological
and biochemical indicators of bone resorption and pathology
[31, 32]. Our current results match studies of knee OA in
patients in which cartilage turnover markers, for example,
urinary CTX II (a biomarker of collagen type II degradation),
increased as radiological and functional indicators of OA
increased [60]. These results also match those in a study by
Frisbe et al. [61] in which serum C1, 2C and CPII levels were
increased in race horses with histological signs of early OA
in mid-carpal joints compared to exercise-alone horses. In
contrast to Frisbe’s study, we did not observe increased CPII
levels in the HRHF + IBU rats compared to resting controls
(NC and TR rats), despite their continued performance of
the HRHF task, suggesting that the increased CPII in our
model is a consequence of the prolonged repetitive loading-
induced cytokine response rather than a direct consequence
of daily activity.
Concerning the eﬀectiveness of ibuprofen, we observed
that 8 weeks of oral ibuprofen had both an anti-inflam-
matory and a chondroprotective eﬀect on wrist joint struc-
tures in our model. Proinflammatory mediators (IL-1α and
TNF-α) were reduced in HRHF + IBU rats compared
to HRHF, and were at normal control levels. Ibuprofen
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also reduced IL-10, an anti-inflammatory and anticatabolic
mediator, in HRHF + IBU limbs compared to HRHF reach
limbs. IL-10 is stimulated by inflammatory mediators (e.g.,
by TNF-α; [62]), upregulated in OA [49], and represents a
feedback mechanism that inhibits inflammatory cytokines.
Confusingly, though, IL-10 was not reduced to baseline levels
in TR + IBU. Therefore, the influence of ibuprofen on IL-
10 concentrations is not straight-forward in our model. We
do feel though that the long-term structural implications of
suppressing IL-10 in HRHF limbs warrant further study.
Histopathological scores were also lower in HRHF +
IBU than untreated HRHF rats, as was the presence of
TUNEL-labeled cells, further supporting a chondroprotec-
tive eﬀect of ibuprofen in our model. Our histopathological
scoring results contradict findings by Jones et al. [33] with
meloxicam, a nonsteroidal anti-inflammatory drug, in a
surgically induced rat model for joint degeneration. In
that study, meloxicam did not attenuate histopathological
changes in articular cartilage. However, treatment with
meloxicam prevented several other common characteristics
of bone remodeling in early joint degeneration, including
peri-articular trabecular bone loss and bone marrow lesion
formation. The discrepancy in histopathological score results
may be related to the use of diﬀerent medications or
the use of diﬀerent joint degeneration models. Also, one
limitation of this current study is that we did not assess peri-
articular trabecular bone changes using microcomputerized
tomography (microCT), thus limiting the comparison of our
findings to those by Jones.
Our observed reduction of serum C1, 2C levels and C1,
2C/CPII ratio in HRHF + IBU rats compared to untreated
HRHF rats further supports the chondroprotective role of
ibuprofen in our repetitive loading model, at least during
this 12-week task period. This result is similar to patients
with active knee OA, who when treated with ibuprofen for
4–6 weeks, had no increase in urinary CTX-II (a biomarker
of collagen type II degradation) compared to patients with
active knee OA treated with placebo only, in which urinary
CTX-II was significantly increased [35]. Oral ibuprofen
treatment for at least 2 weeks also decreases indexes of
pain and functions significantly in patients with active knee
OA, although the eﬀectiveness lessens over time [34, 63],
However, these results contrast with those of Manicourt
et al. [35], in which no reduction in urinary CTX-II or
serum hyaluronan (HA; a marker of synovial inflammation)
was observed in patients receiving a 4-week treatment of
ibuprofen. Petersen et al. [37] also observed that ibuprofen
treatment was not eﬀective in attenuating cartilage turnover
in OA patients in response to physical exercise. Perhaps these
diﬀerences are due to the heterogeneity of OA in the human
population [64].
In conclusion, 12 weeks of a voluntary high-repetition
high-force reaching and handle pulling task represents a
successful model for inducing wrist joint inflammation
and early degenerative changes. Key proinflammatory and
an anti-inflammatory cytokine levels, inflammatory cells,
TUNEL-stained cells and histopathological scores of degen-
eration were elevated in joint tissues by 12 weeks of
performance of this high-demand task. Each of these changes
was attenuated by ibuprofen treatment, suggesting that such
treatment is condroprotective, at least during the early
phases of cumulative loading-induced inflammation and
degeneration in hand and wrist joints.
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